Potencial risks of nanoparticles;Riscos potenciais do nanopartículas

Ciencia e Tecnologia de Alimentos

Volumn 31, Issue 4, 2011, Pages 835-842

  Forbe, Tamara ^a   García, Mario ^a   Gonzalez, Eric ^b  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Centre for Process Engineering (CIPRO)   (Cuba)

Author keywords

Carbon nanotubes; Nanoparticles; Nanotoxicology; Toxicological effects

Indexed keywords

EID: 84855552353     PISSN: 01012061     EISSN: 1678457X     Source Type: Journal    
DOI: 10.1590/S0101-20612011000400002     Document Type: Review

References (35)

1. ACTION GROUP ON EROSION, TECHNOLOGY AND CONCENTRATION. Nanotech product recall underscores need for nanotech moratorium: is the magic gone? Disponível em: http://www.etcgroup.org/upload/publication/14/01/nrnanorecallfinal.pdf. Acesso em: 2006.
2. AZARMI, S. Targeted delivery of nanoparticles for the treatment of lung diseases. Advanced Drug Delivery Reviews, v. 60, n. 8, p. 861-954, 2008. PMid:18308418. http://dx.doi.org/10.1016/j.addr.2007.11.006
3. BORM, P. et al. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicological Sciences, n. 1, p. 23-32, 2006.
4. BOUWMEESTER, H. et al. Review of health safety aspects of nanotechnologies in food production. Regulatory Toxicology and Pharmacology, v. 53, n. 1, p. 52-62, 2009. PMid:19027049. http://dx.doi.org/10.1016/j.yrtph.2008.10.008
5. CHAU, C.; WU, S.; YEN, W. The development of regulations for food nanotechnology. Trends in Food Science & Technology, v. 18, p. 269-280, 2007. PMid:21299575. http://dx.doi.org/10.1016/j.tifs.2007.01.007
6. CURTIS, J. et al. Nanotechnology and nanotoxicology: a primer for clinicians. Toxicological Sciences, v. 25, n. 4, p. 245-260, 2006.
7. DONALDSON, K. et al. Nanotoxicology. Occup Environmental Medicine, v. 61, n. 9, p. 727-728, 2004. PMid:15317911. PMCid:1763673. http://dx.doi.org/10.1136/oem.2004.013243
8. DREHER, K. L. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicological Sciences, v. 77, p. 3-5, 2004. http://dx.doi.org/10.1093/toxsci/kfh041.
9. DUFFIN, R.; MILLS, N. L.; DONALDSON, K. Nanoparticles - a thoracic toxicology perspective. Yonsei Medical Journal, v. 48, n. 4, p. 561-572, 2007. PMid:17722227. PMCid:2628054. http://dx.doi.org/10.3349/ymj.2007.48.4.561.
10. FISCHER, H.; CHAN, W. Nanotoxicity: the growing need for in vivo study. Current Opinion in Biotechnology, v. 18, n. 565-570, 2007.
11. FUJIMOTO, N. et al. Diesel exhaust affects immunological action in the placentas of mice. Environmental Toxicology, n. 4, p. 4331-4340, 2005.
12. HAGENS, W.I. et al. What do we (need to) know about the kinetic properties of nanoparticles in the body?. Regulatory Toxicologyand Pharmacology, v. 49, n. 3, p. 217-229, 2007. PMid:17868963. http://dx.doi.org/10.1016/j.yrtph.2007.07.006
13. HILLYER, J. F.; ALBRECHT, R. M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. Journal of Pharmaceutical Sciences, n. 12, p. 1927-1936, 2001. PMid:11745751. http://dx.doi.org/10.1002/jps.1143.
14. HODGE, G.; BOWMAN, D. Engaging in Small Talk: Nanotechnology Policy and Dialogue Processes in the UK and Australia. The Australian Journal of Public Administration, v. 66, n. 2, p. 223- 237, 2007. http://dx.doi.org/10.1111/j.1467-8500.2007.00530.x
15. HUCZKO, A.; LANGE, H. Carbon nanotubes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Science and Technology, v. 9, n. 2, p. 247-250, 2001. http://dx.doi.org/10.1081/FST-100102972.
16. KAGAN, V. E.; BAYIR, H.; SHVEDOVA, A. A. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine, v. 1, n. 4, p. 313-316, 2005. PMid:17292104. http://dx.doi.org/10.1016/j.nano.2005.10.003
17. LACERDA, L. et al. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Advanced Drug Delivery Reviews, v. 58, n. 14, p. 1460-1470, 2006. PMid:17113677. http://dx.doi.org/10.1016/j.addr.2006.09.015.
18. LANONE, S.; BOCZKOWSKI, J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Current Molecular Medicine, v. 6, n. 6, p. 651-663, 2006. PMid:17022735. http://dx.doi.org/10.2174/156652406778195026.
19. MAYNARD, A. D. et al. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. Journal of Toxicology and Environmental Health, v. 67, n. 1, p. 87-107, 2004. PMid:14668113. http://dx.doi.org/10.1080/15287390490253688.
20. MOGHIMI, S. M.; HUNTER, A. C.; MURRA, Y. J. C. Nanomedicine: current status and future prospects. FASEB Journal, v. 19, n. 3, p. 311-330, 2005. PMid:15746175. http://dx.doi.org/10.1096/fj.04-2747rev
21. NATIONAL NANOTECHNOLOGY INITIATIVE FY. Budget and Highlights [online]. Disponível em: www.nano.gov/pdf/NNI_.FY08_budget_summary-highlights.pdf. Acesso em: 2007.
22. NEL, A. et al. Toxic potential of materials at the nanolevel. Science, n. 31, p. 622-627, 2006. PMid:16456071. http://dx.doi.org/10.1126/science.1114397
23. OBERDORSTER, G. Pulmonary effects of inhaled ultrafine particles. International Archives of Occupational and Environmental Health, v. 74, p. 1-8, 2001. http://dx.doi.org/10.1007/s004200000185
24. OBERDORSTER, G.; MAYNARD A.; DONALDSON, K.; CASTRANOVA, V.; FITZPATRICK, J.; AUSMAN K. Principles for characterizing the potential human health effects from exposureto nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology, v. 2, 2005. Disponível em: http://www.particleandfibretoxicology.com/content/2/1/8.
25. OBERDORSTER, G., OBERDORSTER, E.; OBERDORSTER, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives v.113, p. 823-839, 2005. PMCid:1257642. http://dx.doi.org/10.1289/ehp.7339.
26. ROUSE, J. G. et al. Nanotechnology approaches for drug and small molecule delivery across the blood-brain barrier. Surgical Neurology, n. 2, p. 113-116, 2007.
27. SILVA, G.A. Nanotechnology approaches for drug and small molecule delivery across the blood-brainbarrier. Surgical Neurology, v. 67, n. 2,p. 113-116, 2007. PMid:17254859. http://dx.doi.org/10.1016/j.surneu.2006.08.033
28. SINGH, R. et al. The biocompatibility of carbon nanotubes. Carbon, v. 44, p. 1034-1047, 2006. http://dx.doi.org/10.1016/j.carbon.2005.10.011
29. SMART, S. et al. The Biocompatibility of Carbon Nanotubes. Carbon, v. 44, p. 1034-1047, 2006. http://dx.doi.org/10.1016/j.carbon.2005.10.011
30. TINKLE, S. S. et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environmental Health Perspectives, v. 111, n. 9, p. 1202-1208, 2003. PMid:12842774. PMCid:1241575. http://dx.doi.org/10.1289/ehp.5999
31. TRAN, C. L. et al. A scoping study to identify hazard data needs for addressing risks presented by nanoparticles and nanotubes. Edinburgh: Institute of Occupational Medicine (IOM) Research Report, 2005.
32. Vega-Villa, K. Et Al. Clinical toxicities of nanocarrier systems. Advanced Drug Delivery Reviews, v. 60, p. 929-938, 2008. PMid:18313790. http://dx.doi.org/10.1016/j.addr.2007.11.007
33. WANG, H. et al. Biodistribution of carbon single-wall carbon nanotubes in mice. Journal of Nanoscience and Nanotechnology, v. 4, p.1019-1024, 2004. PMid:15656196. http://dx.doi.org/10.1166/jnn.2004.146
34. WARHEIT, D. B. et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicology Science, v. 77, n. 1, p. 117-125, 2004. PMid:14514968. http://dx.doi.org/10.1093/toxsci/kfg228
35. XIA, T. et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Letters, v. 6, p.1794-1807, 2006. PMid:16895376. http://dx.doi.org/10.1021/nl061025k